Opexa Therapeutics Inc (NASDAQ:OPXA)

0.42
Delayed Data
As of Apr 17
 -0.0053 / -1.25%
Today’s Change
0.40
Today|||52-Week Range
1.75
-41.67%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$12.0M

Company Description

Opexa Therapeutics, Inc. is a biopharmaceutical company developing personalized immunotherapy with the potential to treat major illnesses, including multiple sclerosis. This therapy is based on T-cell technology. The company's therapy candidate, Tcelna, is a personalized T-cell immunotherapy for the treatment of secondary progressive multiple sclerosis. The company was founded in 2004 and is headquartered in The Woodlands, TX.

Contact Information

Opexa Therapeutics, Inc.
2635 Technology Forest Boulevard
The Woodlands Texas 77381
P:(281) 775-0600
Investor Relations:

Employees

Shareholders

Individual stakeholders3.97%
Mutual fund holders2.52%
Other institutional1.95%

Top Executives

Neil K. WarmaPresident, Chief Executive Officer & Director
Donna R. RillChief Development Officer & SVP-Operations
Karthik RadhakrishnanChief Financial Officer
Dawn McGuireChief Medical Officer
Donald HealeyChief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account